Last updated on November 2018

PK Study in Subjects With Severe Hepatic Impairment


Brief description of study

This is an open-label, single-dose study in male and female subjects with severe hepatic impairment and in male and female subjects with normal hepatic function.

Clinical Study Identifier: NCT03664544

Contact Investigators or Research Sites near you

Start Over

Mitsubishi Tanabe Pharma Europe Ltd ...

Investigational Centre
Miskolc, Hungary
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.